Revvity Inc stock is traded at $145.22, with a volume of 1,663,127. It is down -4.20% in the last 24 hours and down -6.92% over the past month. Revvity is a global life sciences and diagnostics company formed in 2023 following the rebranding of PerkinElmer. The company operates in two segments: life sciences, which provides reagents and instruments for biopharma and academic research, and signals software, and diagnostics, which offers tools in immunodiagnostics and newborn and reproductive health. Revvity's products and services are sold worldwide, with major markets in the US, Europe, and China.
Previous Close:
$151.59
Open:
$150.93
24h Volume:
1,663,127
Relative Volume:
1.20
Market Cap:
$16.21B
Revenue:
$2.90B
Net Income/Loss:
$239.11M
P/E Ratio:
68.83
EPS:
$2.11
Net Cash Flow:
$492.62M
1W Performance:
-5.94%
1M Performance:
-6.92%
6M Performance:
+53.19%
1Y Performance:
+54.46%
1-Day Range:
$143.61$150.93
1-Week Range:
$143.61$156.41
52-Week Range:
$81.22$171.74
Revvity Inc Stock (RVTY) Company Profile
Name
Revvity IncSector
HealthcareIndustry
Diagnostics & ResearchPhone
781-663-6900Address
77 4TH AVENUE, WALTHAM, USAMarket Cap
Revenue
Net Income
Cash Flow
EPS